PURPOSE. To achieve a better understanding of the involvement of phospholipases in the inflammation and wound-healing processes in human corneal epithelial cells (HCECs), expression of phospholipase A 2 s (PLA 2 s) and phospholipase Cs (PLCs) was examined in the human corneal epithelium. METHODS. Specific primers were designed for RT-PCR amplification of the known secreted (s)PLA 2 , cytosolic (c)PLA 2 , and PLC mRNAs. Corresponding PCR products were cloned and the DNA sequenced. Immunofluorescence of flatmounted corneal sections and Western blot analyses were used to detect the PLA 2 s and PLCs expressed by HCECs. RESULTS. The mRNAs for the following phospholipases were detected by RT-PCR in the HCECs: sPLA 2 GIII, -GX, and -GXIIA; cPLA 2 ␣ and -␥;
C orneal wound healing is a complex process that can be seriously impaired by inflammation. Indeed, keratitis or corneal inflammation often result in an opacification of the cornea that can usually be successfully treated but may also lead to the loss of vision or of the eye itself. 1 Phospholipases are essential for cell proliferation, differentiation, transformation, apoptosis, 2 and synthesis of potent precursors of mediators of inflammation. 3 Some phospholipases also exhibit antibacterial properties. 4, 5 Phospholipases can therefore be considered major components in corneal wound healing and inflammation processes. 6, 7 Phospholipases hydrolyze membrane phospholipids to induce or transmit signals within the cell. 8 There are different families of phospholipases, among which the phospholipase A 2 s (PLA 2 s) and phospholipase Cs (PLCs) families are physiologically essential. The PLA 2 family is composed of two major subfamilies: secreted (s)PLA 2 and cytosolic (c)PLA 2 , group (G)IV. In mammals, many groups of sPLA 2 s (GIB, GIIA, GIIC, GIID, GIIE, GIIF, GIII, GV, GX, GXIIA, and GXIIB) 9 -12 and four types of cPLA 2 s (␣, ␤, ␥, and ␦; GIVA-D) 11, 13, 14 hydrolyze phospholipids to generate a free fatty acid and a lysophospholipid, both of which can act as lipid signaling molecules. Frequently, the free fatty acid produced is arachidonic acid (AA). 15 AA is the precursor of many potent mediators of inflammation, such as thromboxanes, prostaglandins, and leukotrienes. AA metabolites are, among others, responsible for ocular inflammation. 16 ,17 sPLA 2 s and cPLA 2 s are therefore essential enzymes in the management of corneal inflammation. Furthermore, seven sPLA 2 s demonstrate potent antibacterial properties in vitro against Gram-positive bacteria. 4 ,5 sPLA 2 GIIA accounts, at least in part, for the antibacterial properties of the tears 18 and is secreted by both the lacrimal glands and canals. 19, 20 The corneal epithelium may also be responsible for part of the antibacterial properties of the tears, if it secretes sPLA 2 and -. 26, 27 Some of these isoforms also undergo alternative splicing. PLCs are associated with the plasma membrane (␤, ␥, ␦, and ), 2,25 the cytosol (␤, ␥, ␦, , and ), 2, [25] [26] [27] or the nucleus (␤ and ␥).
2 After activation by the cell receptors, 2 PLCs then preferentially hydrolyze phosphatidylinositol 4,5-bishosphate from the membrane to produce two potent second messengers, inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol (DAG).
2 IP 3 induces the release of intracellular calcium from the endoplasmic reticulum reserves, and the main cellular targets for DAG belong to the protein kinase C (PKC) family. 2 The increase in intracellular calcium activates a very intricate signaling pathway in ocular tissues. 28 It also activates cPLA 2 s through its translocation to the membrane. 29, 30 Phospholipases play a major role in signal transduction (PLCs) and in the release of potent precursors of mediators of inflammation (PLA 2 s and PLCs). These enzymes thus play central roles in the corneal epithelium, with particular reference to wound healing as well as to the antibacterial properties of the tears. However, no information is available on the expression of phospholipases by the human corneal epithelium. In the present study, the identity of the different PLA 2 s and PLCs expressed by human corneal epithelial cells (HCECs) was thus determined at the protein and transcript level by using immunofluorescence of tissue sections, Western blot analyses, and RT-PCR.
MATERIALS AND METHODS
This study was conducted in accordance with our institution's guidelines and the Declaration of Helsinki. The protocols were also approved by the institution's Committee for the Protection of Human Subjects.
Isolation of Human Corneal Epithelium
Fresh corneas were isolated from 62 human donor eyes (age range, 39 -88 years; average, 69) within 24 hours after death through the Banque d'Yeux Nationale (Sainte-Foy, Québec, Canada). Briefly, corneas were dissected according to the procedure described by Gipson and Grill. 31 Epithelial sheets were then transferred to either a reagent for subsequent total RNA extraction (TriReagent; Sigma-Aldrich, St. Louis, MO), or PBS (150 mM NaCl, 9.1 mM Na 2 HPO 4 , and 1.7 mM NaH 2 PO 4 [pH 7.4]) containing 1% (vol/vol) protease inhibitor cocktail (Sigma-Aldrich) for subsequent protein extraction.
Reverse Transcription-Polymerase Chain Reaction
Total RNA was extracted and pooled from human corneal epithelial tissues freshly isolated from 16 human eyes (age range, 48 -84 years; average, 66) using extraction reagent (TriReagent; Sigma-Aldrich), as described previously. 32, 33 
Cloning and DNA Sequencing
The bands containing the PCR products were excised, purified (Ultrafree-DA columns; Millipore, Bedford, MA), and inserted into a cloning vector (pGEM-T Easy; Promega, Madison, WI), according to the manufacturer's instructions. The mixture was transformed into competent Escherichia coli DH5␣ bacterial cells (Invitrogen). The transformed cells were then plated and grown to a stationary phase and plasmid purification was performed (QIAprep Spin Miniprep kit; Qiagen, Mississauga, Ontario, Canada). DNA sequencing of positive clones was performed by the Service d'Analyse et de Synthèse d'Acides Nuclé-iques at Université Laval (Sainte-Foy), using T7 sequencing primers.
Indirect Immunofluorescence of Corneal Cryosections
Tissue biopsies (corneas) were obtained from the eyes of a 52-year-old human donor. Corneas were embedded in optimal cutting temperature (OCT) compound (Tissue-Tek; Bayers Canada, Etobicoke, Ontario, Canada), frozen in liquid nitrogen, and stored at Ϫ80°C until use. Indirect immunofluorescence assays were performed on acetone-fixed, 5-m-thick cryosections, as previously reported. 34 Sections were incubated with primary antibodies (Table 2) diluted 1:50. The large-scale production of the sPLA 2 GIII, -GX, or -GXIIA antibodies has been reported, 35 except for the sPLA 2 GIII antiserum, which was prepared in rabbits, as described for the other anti-sPLA 2 s antisera, 35 by using as an 
SDS-PAGE and Western Blot Analyses
Proteins from the human corneal epithelium (60 g) and from each positive control (50 g) were separated on a 6% (PLCs), 8% (cPLA 2 s and PLC␦s), or 15% (sPLA 2 s) (wt/vol) polyacrylamide gel. Prestained broad-range protein molecular weight standards (MBI Fermentas, Burlington, Ontario, Canada) were used for calibration. The proteins from the gel were transferred onto a polyvinylidene difluoride membrane (Amersham Biosciences) for sPLA 2 s, or onto a nitrocellulose membrane (Bio-Rad) for cPLA 2 s and PLCs. The membranes were blocked, incubated with primary antibodies (Table 2) , washed, and incubated with secondary antibodies (Table 2 ). The membranes were washed and then soaked in tris-buffered saline (TBS). These immunoconjugates were detected with the chemiluminescent substrate (SuperSignal West Pico; Pierce), and blots were visualized (Fluor-S Max System; Bio-Rad) except for PLC␦3, with which an autoradiographic film was used to reduce background.
RESULTS

PLA 2 and PLC mRNAs Expression by HCECs
RT-PCR experiments revealed the expression of mRNAs for sPLA 2 GIII, -GX, and -GXIIA (Fig. 1A) in the corneal epithelium, with an apparent size of 500, 327, and 723 bp, respectively, as was expected with the primers used ( Table 1) . As shown in Figure 1B , cPLA 2 ␣ and -␥ mRNA transcripts were expressed by HCECs, with a respective apparent size of 440 and 1020 bp (Table 1) . Many different mRNA transcripts of PLCs were present in HCECs, including PLC␤1, -␤2, -␤3, -␤4, -␥1, -␥2, -␦1, -␦3, -␦4, and -( Fig. 1C ) with apparent sizes of 690, 620, 550, 500, 924, 882, 458, 716, 468 and 700 bp, respectively, as expected with the primers used ( Table 1) . sPLA 2 GIB, -GIIA, -GIID, -GIIE, and -GIIF (Fig. 1A) ; cPLA 2 ␤ (Fig. 1B) and -␦ (data not shown); and PLC␦2 and -1 (data not shown) mRNA transcripts were not amplified in the corneal epithelium. After cloning and sequencing of the PCR products, identities of the different phospholipases were confirmed by comparison with the known phospholipase sequences using BLASTn (www. ncbi.nlm.nih.gov/BLAST). Additional bands were observed for some of the PLCs-namely, ␤1, ␤3, ␥1, ␥2, and (Fig. 1C) . Moreover, faint bands were also observed for sPLA 2 IID and -IIF (Fig. 1A) . These bands were excised from the agarose gel, cloned, sequenced, and found to correspond to nonspecific PCR products.
PLA 2 and PLC Protein Expression by the Corneal Epithelium
As shown in Figure 2 , indirect immunofluorescence analyses conducted on corneal cryosections revealed the presence of sPLA 2 GIII, -GX, and -GXIIA (Fig. 2A) ; cPLA 2 ␣ and -␥ (Fig. 2B) ; and PLC␤2, -␤3, -␥1, and -␥2 proteins (Fig. 2C) . PLC␤1, -␤4, -␦1, -␦3, and -proteins were not detected in corneal epithelium (data not shown). It can be seen in the micrographs in Figure  2 that all phospholipases were present in the cytoplasm of HCECs. sPLA-GIII and -GXIIA, cPLA 2 ␣ and -␥, and PLC␥1 were also present in the nucleus. Whereas PLC␤3 was present uniformly in the cytoplasm of the cells throughout the epithelium, it is also markedly present in the basal region of the basal cells. sPLA 2 GIII and -GXIIA and cPLA 2 ␣ and -␥ were markedly present in the apical region of the cornea. It is interesting to note that among all PLA 2 s and PLCs tested, many are also expressed by stromal fibroblasts, particularly PLC␥2. To further validate these data, Western blot analyses were conducted on crude protein extracts obtained from the corneal epithelium of donor eyes. As shown in Figure 3A , protein bands with apparent molecular masses of 55, 20, and 21 kDa corresponding to sPLA 2 GIII, -GX, and -GXIIA, respectively, were detected in the human corneal epithelium. Protein bands with apparent molecular masses of 85 and 60 kDa corresponding respectively to cPLA 2 ␣ and -␥, were detected in the human corneal epithelium (Fig. 3B) . Similarly, protein bands with apparent molecular masses of 140, 150, 155, 120, and 85 kDa, corresponding respectively to PLC␤2, -␤3, -␥1, -␥2, and -␦3 (Fig. 3C) were detected in the human corneal epithelium. The disagreement between the indirect immunofluorescence and Western blot analyses for PLC␦3 can be explained by the presence of a very low expression of PLC␦3 in this tissue, since a 1-hour exposure of the membrane was necessary to observe the PLC␦3 band at 85 kDa. The molecular masses of these bands are in good agreement with those obtained with the positive controls provided by the manufacturer (Fig. 3C) , except for PLC␥2, which was 20 kDa lower than the positive control. This latter result could be explained by N-terminal proteolysis (epitope mapping at the C terminus), as no splicing has been reported for the PLC␥2 transcript. No protein was detected with PLC␤1, -␤4, -␦1, and -antibodies (data not shown), in contrast with the data reported by Islam and Akhtar, 36 who observed the presence of PLC␤1 in their cultures of rabbit corneal epithelium. This can be explained either by differences in the expression of PLCs in human and rabbit corneal epithelium or by the treatment of their corneal epithelium with epidermal growth factor (EGF). These data thus suggest that only sPLA 2 GIII, -GX, and -GXIIA; cPLA 2 ␣ and -␥; and PLC␤2, -␤3, -␥1, -␥2, and -␦3 are expressed by the human corneal epithelium.
Additional bands were observed for three of these phospholipases: sPLA 2 GXIIA, cPLA 2 ␣, and PLC␥2. Indeed, four bands of high molecular mass were detected for sPLA 2 GXIIA which likely correspond to different levels of aggregation of this enzyme. In addition, five and two bands of low molecular weight were detected respectively for cPLA 2 ␣ and PLC␥2 which may correspond to protein degradation.
DISCUSSION
No information was available on the expression of phospholipases by the human corneal epithelium. In fact, most of the studies on the expression of ocular phospholipases and their regulation were conducted using rabbit eyes. 8, 17, 19, 36 It is important to investigate the expression of phospholipases in the human eye because of the limitations of extrapolating from animal models. This is especially true of data derived from the rabbit eye, 17 which has a much higher rate of AA metabolism than either the human or bovine eye. 37 In the present study, the identity and localization of the different PLA 2 s and PLCs expressed by the human corneal epithelium were thus determined.
The antibacterial properties of sPLA 2 s are well recognized and may be the result of their catalytic action. 4, 5 The sPLA 2 GIIA present in tears 5 originates from lacrimal ducts and glands 19, 20 and accounts in part for the antibacterial properties of the tear film. However, sPLA 2 GIIA is not expressed by the corneal epithelium, which thus does not contribute to the production of this enzyme in the tear film. In vitro, sPLA 2 GIIA showed the strongest bactericidal activity against Gram-positive bacteria, followed by sPLA 2 GX, -GV, and -GXIIA. 4 Only sPLA 2 GXIIA demonstrated a detectable bactericidal activity against the Gram-negative bacteria Escherichia coli. 4 We demonstrated an even distribution of sPLA 2 GX proteins in the cytosol of HCECs and a cytosolic/nuclear distribution of sPLA 2 GIII and -GXIIA. It would be of interest to determine whether sPLA 2 GIII, -GX, and -GXIIA proteins can indeed be found in tears and then contribute to the antibacterial properties of the tear film. If this were indeed the case, then sPLA 2 s activity in tears would originate from lacrimal ducts and glands as well as HCECs, providing even more antibacterial protection to help maintain the sterility of a wound or at least fight against infection after corneal injury. cPLA 2 ␣ mRNA is ubiquitously expressed in most adult human tissues, 38, 39 whereas cPLA 2 ␥ mRNA is selectively expressed in some tissues. 38, 40, 41 In this study, we demonstrated the expression of these two proteins in the cytosol and nucleus of corneal epithelial cells. cPLA 2 ␣ has attracted special interest, because it is the only one of numerous PLA 2 s that selectively release AA over other fatty acids. 42, 43 cPLA 2 ␣ initiates the immediate AA release. 3 Its expression is elevated in some tissues in response to pathologic stimuli. 44 -47 cPLA 2 ␥ properties and regulation are less well known. Asai et al. 48 demonstrated that cPLA 2 ␥ remains bound to membranes due to its lipid anchor at its C terminus. 41 The immunofluorescence analyses of corneal tissue sections conducted in the present study demonstrated that this protein was markedly present on the cell membrane of HCECs. By using a cPLA 2 ␣ inhibitor, Kang et al. 49 have determined that EGF induces the production of prostaglandins through the activation of this cPLA 2 in rabbit corneal epithelial cells. Given that the EGF level increases during corneal wound healing, 50 -52 the cPLA 2 ␣ expressed by HCECs may be involved in corneal wound healing. Moreover, it has been proposed that increased expression of a cPLA 2 in the corneal epithelium takes place after a platelet-activating factor (PAF) stimulus. 53, 54 Given that PAF is well known to mediate inflammatory and immune responses, these data suggest that cPLA 2 ␣ expressed by the corneal epithelium may be involved in these processes.
Because of their ability to induce numerous effects after hydrolysis of phospholipids, 2 PLCs are believed to be important cell-signaling components during wound healing and inflammation processes. A wide variety of mRNAs coding for PLC isoforms were identified in HCECs (PLC␤1, -␤2, -␤3, -␤4, -␥1, -␥2, -␦1, -␦3, -␦4, and -). However, in normal HCECs, only part of these mRNA are translated into proteins (PLC␤2, -␤3, -␥1, -␥2, and -␦3). The other ones may then be expressed in pathologic conditions or after a proper stimulation by a growth factor as observed for PLC␥1 in EGF in cultures of rabbit corneal epithelium. 36 Moreover, it is interesting to point out the variation in the localization of PLC proteins within the HCECs. PLC␤2, -␤3, -␥1, and -␥2 proteins are all present throughout the cytoplasm of HCECs; PLC␤2 was more concentrated at the cell membrane, whereas PLC␤3 was very much present on the basal side of the basal cell layer of the corneal epithelium. PLC␥1 protein was also present in the nucleus of basal and intermediate cells, whereas PLC␥2 was the only phospholipase strongly detected in stromal fibroblasts among all those examined. This difference in cellular localization reinforces the hypothesis that the different PLC isoforms may play several critical functions within these cells in normal and most probably under pathologic conditions. In this regard, it has been shown that EGF stimulates the expression of PLC␥1. 36, 49, 55 This PLC may be involved in corneal wound healing, given the involvement of EGF in this process. 50 -52 Moreover, by using a specific PLC inhibitor, Huang et al. 56 have shown that the production of bradykinin, which is released during the inflammatory response of the cornea, leads to the activation of a PLC in canine cultured corneal epithelial cells.
The respective function played by each phospholipase (PLA 2 and PLC) must be determined, to achieve a better understanding of their involvement in inflammation and wound healing of the corneal epithelium. It is clear that phospholipases play important roles in ocular physiology and pathophysiology and that modulation of their synthesis, sites of FIGURE 2. Immunofluorescence analysis of phospholipases expressed by the human cornea. Immunolocalization of all phospholipases was performed using the (A) sPLA 2 , (B) cPLA 2 , and (C) PLC antibodies shown, and further revealed with a secondary antibody labeled with TRITC or Alexa 594 (Table 2) . Nuclei were counterstained with Hoechst 33258 reagent. Negligible background was observed in control experiments, in which primary antibodies were omitted (data not shown). The corneal epithelium (e) and stroma (s) are indicated in (A). Scale bar, 100 m.
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action, and inactivation comprise important pharmacological targets for the management of ocular disorders. Such knowledge could lead to new studies to determine which phospholipases represent good therapeutic targets in the establishment of a specific treatment for inflammatory disorders.
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FIGURE 3.
Western blot analysis of phospholipases in crude extracts from HCECs. Western blot analyses were performed using the (A) sPLA 2 , (B) cPLA 2 , and (C) PLC antibodies shown ( 
